Improved Clinical Outcomes
In addition to cutting costs, Fresenius Health Partners improves the clinical outcomes of ESRD patients. Our competitors cannot match the outcomes of our comprehensive program as summarized below. This performance has been recently validated by the CMS (Centers of Medicare & Medicaid Services) ESRD Demonstration Project.
Fistula Prevalence
An arterio-venous fistula (also known as the AV Fistula or AVF) is the preferred type of access because it is the safest and has the lowest risk of infection. 61% of Fresenius Health Partners members have an AV fistula for dialysis access, as compared to 50% of dialysis patients nationwide.
The United States Renal Data System (USRDS) is a national data system that collects, analyzes, and distributes information about ESRD (End Stage Renal Disease) in the United States.
Reduced Hospitalizations
Hospital Admissions are reduced by more than a third with the Fresenius Health Partners program. Fresenius Health Partners members have a hospitalization rate of 1.27 admissions per year as compared to the national dialysis population of 1.97 admissions per year.
The United States Renal Data System (USRDS) is a national data system that collects, analyzes and distributes information about ESRD (End Stage Renal Disease) in the United States.
Mortality Rates
Fresenius Health Partners reduces the mortality rate by 45%.
The mortality rate is 20.1 deaths per 100 patient years on dialysis nationwide, compared to the mortality rate of 11.2 deaths per 100 patient years within the Fresenius Health Partners population. Patient year is a number that reflects the amount of time that each patient spent on dialysis.
The United States Renal Data System (USRDS) is a national data system that collects, analyzes and distributes information about ESRD (End Stage Renal Disease) in the United States.